(9545756), N. E. O., (3592601), H. E., (9545759), K. A. E., (9279245), D. T., (79420), S. D., (832403), D. A., . . . (9545771), A. H. (2025). Extent and Mitigation of Financial Toxicity of Immune Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma.
Chicago Style (17th ed.) Citation(9545756), Nabil E. Omar, Hazem Elewa (3592601), Kareem A. El-Fass (9545759), Dario Trapani (9279245), Said Dermime (79420), Daoud Al-Badriyeh (832403), Dina Abushanab (10696501), and Anas Hamad (9545771). Extent and Mitigation of Financial Toxicity of Immune Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma. 2025.
MLA (9th ed.) Citation(9545756), Nabil E. Omar, et al. Extent and Mitigation of Financial Toxicity of Immune Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma. 2025.